Casey Mulligan on Vaccines, the Pandemic, and the FDA
EconTalk
00:00
Intro
This chapter explores the historical implications of the FDA's 1962 mandate on drug regulation, focusing on the balance between ensuring drug efficacy and promoting market innovation. Through a critical analysis of trends in drug approval and sales, the discussion reveals how increased regulatory barriers have shaped the pharmaceutical landscape.
Play episode from 00:00
Transcript
